Sense Biodetection Limited announced that it has received ?47.04115 million in funding from Mercia Asset Management PLC, Earlybird Venture Capital GmbH & Co. KG, Cambridge Innovation Capital Limited, Koch Disruptive Technologies, LLC

On November 16, 2021, Sense Biodetection Limited closed the transaction. The company amended the terms of the transaction. The company received its third and final tranche of $15,000,000 (?11,176,650) in funding bringing its total series B funding to $65,000,000 (?47,041,150). The tranche was led by Koch Disruptive Technologies, LLC. The tranche included participation from existing investors.